Duopharma Biotech Bhd MYX:DPHARMA:
QTRLY REVENUE 222.5 MILLION RGT
QTRLY PROFIT ATTRIBUTABLE 22.6 MILLION RGT
Duopharma Biotech Posts Qtrly Revenue 222.5 Million RGT
Later from Duopharma Biotech
- Duopharma Biotech Appoints Puan Rohayu Rosnani Binti Mohd Adanan As CFO
- Duopharma Biotech Says Government Accepts Tender Offer For Supply Of Insulin Injection By Unit
- Duopharma Biotech Reports Quarterly Profit Attributable Of 30.71 Million RGT
- Duopharma Biotech Says Government Accepts Duopharma (M) Sendirian Tender
Follow Duopharma Biotech into a list and get an email when it puts out news.
Follow Duopharma Biotech